FFP sole source contract for employee and patient drug testing at the minneapolis VAMC

Ended Definitive Contract Awarded Last action

Contract number
36C26318C0021
Awardee
Awarding agency
Obligated
$96,658

Award facts

Contract value 65% obligated
  • $96,657.58 Current, with exercised options
  • $149,541.82 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Minneapolis, MN 55417, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 · Drug tests at the minneapolis VAMC OY4 deob -$4,344
Supplemental Agreement for work within scope P00012 -$5,292
Supplemental Agreement for work within scope P00011 -$5,779
Exercise an Option P00010 $26,442
Supplemental Agreement for work within scope P00009 · Additional verbiage drug tests at the minneapolis VAMC $0
Supplemental Agreement for work within scope P00007 · Additional drug tests at the minneapolis VAMC $0
Supplemental Agreement for work within scope P00008 · Drug tests at the minneapolis VAMC -$10,862
Exercise an Option P00006 · Option year 3 of drug tests at the minneapolis VAMC $26,442
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 · Additional drug tests at the minneapolis VAMC $0
Supplemental Agreement for work within scope P00002 -$9,276
Exercise an Option P00003 $26,442
Exercise an Option P00001 $26,442
Original award $26,442
Show all 14

About this award

This is a firm fixed price (FFP) sole source contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The contract, valued at $149,541.82, is for employee and patient drug testing services at the Minneapolis VA Medical Center. Medtox Laboratories holds a General Services Administration (GSA) Multiple Award Schedule contract, through which it provides laboratory supplies and services to federal customers, including the Indian Health Service (IHS). The company has received numerous prime contracts with IHS to deliver drug screening test kits, analyzer cartridges, and other lab supplies to support substance abuse screening programs. Medtox also holds a $700,000 GSA Multiple Award Schedule contract to provide lab supplies and services through June 2025, with several task orders issued by IHS thus far. This contract does not utilize a set-aside designation.

Quick answers

Who was awarded contract 36C26318C0021?

36C26318C0021 was awarded to Medtox Laboratories Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on May 1, 2018.

How much is contract 36C26318C0021 worth?

The government has obligated $96,658 on 36C26318C0021. Its potential value, with all options, is $149,542.

Was contract 36C26318C0021 competed?

The extent of competition for 36C26318C0021 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award